JPL Wealth Management’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
JPL Wealth Management's NAGE Position: Q3 2026 in Review
JPL Wealth Management sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 5 shares — an estimated $16 sold.
JPL Wealth Management first reported a position in NAGE in Q1 2026 and held it in 2 quarters. The position peaked at $146 in Q1 2026. 111 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- JPL Wealth Management reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
- JPL Wealth Management sold 5 Niagen Bioscience shares in Q3 2026, an estimated $16.
- JPL Wealth Management first reported a position in Niagen Bioscience in Q1 2026 and held it in 2 quarters.
- JPL Wealth Management's Niagen Bioscience position peaked at $146 in Q1 2026.
- 111 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.